173 related articles for article (PubMed ID: 32079521)
21. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
22. Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1
Min R; Wu W; Wang M; Tang L; Chen D; Zhao H; Zhang C; Jiang Y
Molecules; 2019 May; 24(10):. PubMed ID: 31108884
[TBL] [Abstract][Full Text] [Related]
23. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
24. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
Frigon L; Pascal JM
Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
[TBL] [Abstract][Full Text] [Related]
25. Using Clickable NAD
Zhang L; Lin H
Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
[TBL] [Abstract][Full Text] [Related]
26. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold.
Elmasry GF; Aly EE; Awadallah FM; El-Moghazy SM
Bioorg Chem; 2019 Jun; 87():655-666. PubMed ID: 30952061
[TBL] [Abstract][Full Text] [Related]
28. The rise and fall of poly(ADP-ribose): An enzymatic perspective.
Pascal JM; Ellenberger T
DNA Repair (Amst); 2015 Aug; 32():10-16. PubMed ID: 25963443
[TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose): PARadigms and PARadoxes.
Bürkle A; Virág L
Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
[TBL] [Abstract][Full Text] [Related]
30. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
Ruf A; Rolli V; de Murcia G; Schulz GE
J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
[TBL] [Abstract][Full Text] [Related]
32. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
33. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
[TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
35. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress.
Hegedűs C; Virág L
Redox Biol; 2014; 2():978-82. PubMed ID: 25460733
[TBL] [Abstract][Full Text] [Related]
36. [Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions].
Drel' VR; Shymans'kyĭ IO; Sybirna NO; Velykyĭ MM
Ukr Biokhim Zh (1999); 2011; 83(6):5-34. PubMed ID: 22364016
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
[TBL] [Abstract][Full Text] [Related]
38. Hydrofluoric Acid-Based Derivatization Strategy To Profile PARP-1 ADP-Ribosylation by LC-MS/MS.
Gagné JP; Langelier MF; Pascal JM; Poirier GG
J Proteome Res; 2018 Jul; 17(7):2542-2551. PubMed ID: 29812941
[TBL] [Abstract][Full Text] [Related]
39. Free energy calculation provides insight into the action mechanism of selective PARP-1 inhibitor.
Cao R
J Mol Model; 2016 Apr; 22(4):74. PubMed ID: 26969680
[TBL] [Abstract][Full Text] [Related]
40. SnapShot: ADP-Ribosylation Signaling.
Hottiger MO
Mol Cell; 2015 Jun; 58(6):1134-1134.e1. PubMed ID: 26091348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
